Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
High Dose vs Standard Dose Omeprazole in Critically Ill Patients
NCT03388463Completed
- Sponsor
- Menoufia University
- Start
- May 2016
- Primary completion
- Aug 2017
- Modality
- Small Molecules
01
Overview
Randomised, single-blind trial of omeprazole in upper gastrointestinal bleeding (UGIB) (2 arms), sponsored by Menoufia University. Primary endpoint: Significant upper gastrointestinal bleeding at 20 days. Started May 2016; status: completed.
02
Drugs
omeprazole
03
Conditions
upper gastrointestinal bleeding (UGIB)
Beyond the preview
Go deeper on NCT03388463.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03388463.